Cargando…
Combined Gene Expression and RNAi Screening to Identify Alkylation Damage Survival Pathways from Fly to Human
Alkylating agents are a key component of cancer chemotherapy. Several cellular mechanisms are known to be important for its survival, particularly DNA repair and xenobiotic detoxification, yet genomic screens indicate that additional cellular components may be involved. Elucidating these components...
Autores principales: | Zanotto-Filho, Alfeu, Dashnamoorthy, Ravi, Loranc, Eva, de Souza, Luis H. T., Moreira, José C. F., Suresh, Uthra, Chen, Yidong, Bishop, Alexander J. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839732/ https://www.ncbi.nlm.nih.gov/pubmed/27100653 http://dx.doi.org/10.1371/journal.pone.0153970 |
Ejemplares similares
-
Pathway Distiller - multisource biological pathway consolidation
por: Doderer, Mark S, et al.
Publicado: (2012) -
A Network of Conserved Damage Survival Pathways Revealed by a Genomic RNAi Screen
por: Ravi, Dashnamoorthy, et al.
Publicado: (2009) -
Correction: A Network of Conserved Damage Survival Pathways Revealed by a Genomic RNAi Screen
por: Ravi, Dashnamoorthy, et al.
Publicado: (2009) -
FlyRNAi: the Drosophila RNAi screening center database
por: Flockhart, Ian, et al.
Publicado: (2006) -
FlyRNAi.org—the database of the Drosophila RNAi screening center and transgenic RNAi project: 2017 update
por: Hu, Yanhui, et al.
Publicado: (2017)